Status | Study |
Completed |
Study Name: Regulation of Bone Formation in Renal Osteodystrophy Condition: Secondary Hyperparathyroidism Renal Osteodystrophy Date: 2007-11-13 Interventions: Drug: 1 alpha D2 Vitamin D ste |
Completed |
Study Name: 12-month Study of AMG 073 in Renal Osteodystrophy Condition: Renal Osteodystrophy Date: 2007-09-06 Interventions: Drug: AMG 073 30 mg QD orally |
Completed |
Study Name: Serum Uremic Toxins and Histological Findings of the Blood Vessels in Dialysis Patients Condition: Chronic Renal Failure Date: 2006-12-12 |
Completed |
Study Name: Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD Condition: Renal Osteodystrophy Date: 2006-08-14 Interventions: Device: Low magnitude mechanical stimuli 20 minutes standing on low magnitude high frequency vibrating p |
Completed |
Study Name: The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients Condition: Hyperphosphatemia Date: 2006-04-18 Interventions: Drug: Niacinamide |
Completed |
Study Name: The Prevalence of Osteoporosis in Hemodialysis Patients Condition: Osteoporosis Date: 2006-03-29 |
Completed |
Study Name: Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease Condition: Renal Osteodystrophy Date: 2006-01-31 Interventions: Drug: doxercalciferol form of |
Terminated |
Study Name: Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia Condition: Chronic Kidney Disease End Stage Renal Disease Hyperphosph Date: 2005-09-12 |
Completed |
Study Name: Osteopenia and Renal Osteodystrophy: Evaluation and Management Condition: Osteopenia Renal Osteodystrophy Date: 2005-04-14 Interventions: Drug: pamidronate |
Completed |
Study Name: Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis Condition: Renal Osteodystrophy End Stage Renal Disease Date: 1999-10-18 Interventions: Drug: calcitriol Drug: growth hormone |